World Cancer Day | 4 February

World Cancer Day is the one singular initiative under which the entire world can unite together in the fight against the global cancer epidemic. It takes place every year on 4 February.

World Cancer Day, organized by the Union for International Cancer Control (UICC) and celebrated each year on 4 February, is an opportunity to rally the international community to end the injustice of preventable suffering from cancer.

This year’s theme, “I can, we can” acknowledges that everyone has the capacity to address the cancer burden. We can work together to reduce cancer risk factors. We can overcome barriers to early diagnosis, treatment and palliative care. We can work together to improve cancer control and achieve global targets to reduce premature mortality from cancer and NCDs.

World Cancer Day aims to save millions of preventable deaths each year by raising awareness and education about cancer, and pressing governments and individuals across the world to take action against the disease.

UICC ( Union for International Cancer Control ) continues to expand on the success and impact of the day and is committed to ensuring that year-on-year the event is seen and heard by more people around the world. We do this through working directly with our members to develop a campaign that serves their differing organisational priorities; this is achieved through a two-pronged strategic approach.

• UICC provides support through the development of tools and guidance to encourage its member organisations to run local cancer awareness campaigns that are aligned and adapted to the global World Cancer Day message.
• On an above-country level, we work to secure and support digital, traditional and social media opportunities to raise public awareness of the day. Through the continued support of our membership and key partners, World Cancer Day is beginning to firmly cement itself in calendars across the world.

“Our support for World Cancer Day will help elevate the need for access to early detection and diagnosis, as an enabler to precise treatment.  On behalf of Diaceutics, I am honored to be a part of this effort and I will relentlessly drive better testing.-“Peter Keeling, CEO,Diaceutics”